| Document |
Document Title |
|
WO/2023/027529A1 |
The present invention relates to a Bacillus thuringiensis JNU01 (accession number: KCTC 14427BP) strain having a plastic decomposition activity. The Bacillus thuringiensis JNU01 strain according to the present invention can decompose pla...
|
|
WO/2023/025235A1 |
Provided is use of exopolysaccharides of a lactic acid bacterium or a pharmaceutical composition comprising the exopolysaccharides in the manufacture of a medicament for preventing, ameliorating and/or treating a sleeping disorder in a s...
|
|
WO/2023/025292A1 |
Provided is Bacillus coagulans DHE002 preserved and numbered as CGMCC NO.23118. Meanwhile, provided is a method for catalytic production of 2'-deoxyadenosine by fermenting and culturing Bacillus coagulans DHE002 as an enzyme source.
|
|
WO/2023/024828A1 |
Disclosed in the present invention are a glycosyltransferase mutant and a method for catalytic synthesis of rebaudioside M by means of using same. The mutant is obtained by means of performing a mutation on the basis of an amino acid seq...
|
|
WO/2023/019723A1 |
Provided are a monoclonal antibody 32C7, and a preparation method therefor and the use thereof. The monoclonal antibody can effectively and specifically bind to a RBD domain of a S protein of a novel coronavirus, and in-vivo replication ...
|
|
WO/2023/022628A1 |
The invention relates to the field of biotechnology. Claimed is a planktonic eurybiontic strain of unicellular green microalgae Chlorella sorokiniana AGT, capable of photosynthesis at temperatures of from 6°С, deposited in the Russian ...
|
|
WO/2023/019821A1 |
The present invention provides an azaphilone polymer compound, and a preparation method therefor and the use thereof. According to the present invention, muyocopronlaterale is fermented and cultured, and a fermentation product is separat...
|
|
WO/2023/020634A1 |
Disclosed is a genetically engineered bacteria having enhanced superoxide dismutase activity. Using the genetically engineered bacteria can improve the conversion rate of substrates and the yield of products, and shorten the fermentation...
|
|
WO/2023/019724A1 |
Provided are a monoclonal antibody 35B5, a preparation method therefor, and a use thereof. By preparing a neutralizing antibody 35B5 against the RBD domain of a novel coronavirus, it is verified in vitro, by means of surface plasmon reso...
|
|
WO/2023/020191A1 |
Disclosed in the present application are an Exiguobacterium indicum YAN2 having high-concentration selenite tolerance, the preservation number thereof being GDMCC No. 61594, and a method for fermenting inorganic selenium into nano-seleni...
|
|
WO/2023/019671A1 |
A method and a kit for constructing a fluorescent oligonucleotide standard curve. The method comprises: step 1, using an aqueous solution of ammonia to formulate a standard solution of fluorescent oligonucleotide. The fluorescent oligonu...
|
|
WO/2023/019987A1 |
The present invention belongs to the field of food processing, and discloses a neutral exopolysaccharide of lactobacillus plantarum and the use thereof. The neutral exopolysaccharide of lactobacillus plantarum of the present invention is...
|
|
WO/2023/023195A1 |
Provided herein are dairy-like analogue compositions and the methods of making the same using recombinant single variants of casein proteins, including, for example, recombinant single variants of alpha casein proteins.
|
|
WO/2023/019693A1 |
The present invention designs and constructs five artificial non-coding RNAs, respectively. The sequence of each artificial non-coding RNA has a complementary pairing region with a target mRNA, a binding site of an Hfq protein, and a Rho...
|
|
WO/2023/023642A2 |
The present disclosure is generally related to recombinant microbial cells expressing heterologous proteins of interest. Certain aspects of the disclosure are therefore related to, inter alia, recombinant Bacillus cells having enhanced p...
|
|
WO/2023/018718A1 |
This disclosure describes recombinant Megasphaera microbes designed to include increased consumption of acetate, increased carbon flux to butyryl-CoA and/or hexanoyl-CoA, increased production of butyrate and/or hexanoate, or a combinatio...
|
|
WO/2023/015965A1 |
Provided are a high immune yeast cell wall, and a preparation method therefor and the use thereof. For the high immune yeast cell wall, the dissolution rate is ≥ 40%, glucan with a relative molecular weight of 80-200 kDa accounts for m...
|
|
WO/2023/015870A1 |
Provided in the present invention are a method for constructing a strain for producing a recombinant protein containing unnatural amino acids, and the strain obtained therefrom. The method comprises modifying the expression of a prfA gen...
|
|
WO/2023/018691A1 |
Disclosed herein are compositions and methods for preventing, ameliorating, or treating pathogenic infections in aquaculture and/or reducing the severity of one or more risk factors, signs, or symptoms associated with pathogenic infectio...
|
|
WO/2023/018077A1 |
The present invention relates to: a Microccocus cohnii MC-2 strain; a lysate, a culture solution, and an extract solution thereof; a composition comprising same; and a use thereof for improving the condition of skin. A novel Microccocus ...
|
|
WO/2023/015805A1 |
A Bacillus velezensis bred by ultrasound-assisted adaptive evolution, and an application thereof. The Bacillus velezensis comprises a Bacillus velezensis stain US-ALE-BV3 with a preservation number of CGMCC No. 22846 and a Bacillus velez...
|
|
WO/2023/015441A1 |
Provided are a light-controlled lysis engineering bacterium, and a construction method therefor and the use thereof. The light-controlled lysis engineering bacterium can respectively express a photosensitive protein, an anti-termination ...
|
|
WO/2023/016387A1 |
Provided is a Bacillus amyloliquefaciens HDCC00252, the deposit number thereof being CGMCC No. 22781. Also provided is a method for producing 1-deoxynojirimycin by means of fermentation culture of the Bacillus amyloliquefaciens HDCC00252.
|
|
WO/2023/015440A1 |
Provided are an engineering bacteria for tumour therapy based on bacterial biofilm, a construction method therefor, and an application thereof, the engineering bacteria for tumour therapy comprising a photosensitive gene expression casse...
|
|
WO/2023/010982A1 |
Provided is a preparation method for bio-based 1,3-propanediol, comprising: using renewable biomass as a raw material, using Klebsiella fermentation to produce 1,3-propanediol, obtaining a 1,3-propanediol fermentation broth, and then suc...
|
|
WO/2023/010787A1 |
The present invention provides a method for producing a polyhydroxyalkanoate (PHA) by fermentation of agricultural wastes. In the present invention, a fermentation substrate is agricultural wastes, comprising a mixture of livestock and p...
|
|
WO/2023/010789A1 |
A gRNA targeting a blaTEM drug-resistant gene and a drug-resistant plasmid carrying the blaTEM, a horizontally transferred gene knockout vector, and the use thereof in the reduction of the blaTEM drug-resistant plasmid. The provided gRNA...
|
|
WO/2023/014048A1 |
The present invention relates to a novel microorganism, a lysate thereof, a culture medium, an extract of the culture medium, vesicles, and anti-inflammatory and/or antibacterial uses thereof. A novel strain and vesicles derived therefro...
|
|
WO/2023/011576A1 |
Provided are a method for constructing a microorganism with a high yield of lactoyl-n-tetrasaccharide, and an application. A strain constructed in a previous stage for efficiently producing the precursor substance lactoyl-N-trisaccharide...
|
|
WO/2023/011668A1 |
Disclosed in the present invention are a perinaphthenone compound and the use thereof. The compound can bind to E3 ubiquitin ligase tripartite motif 25 (TRIM25), thereby facilitating the recognition of TRIM25 to a pathogen and inducing p...
|
|
WO/2023/014651A1 |
The present disclosure describes products formulated to inhibit respiratory conditions and symptoms in animals, along with associated methods of providing such products to the animals. Feeding methods involve providing animals with a fee...
|
|
WO/2023/014054A1 |
The present invention relates to a novel microorganism, a lysate thereof, a culture medium, an extract of the culture medium, a vesicle, and anti-inflammatory and/or antibacterial uses thereof. A novel strain and a vesicle derived theref...
|
|
WO/2023/010910A1 |
Provided are an organic selenium-enriched yeast, a preparation method therefor, a product, and an application. The organic selenium-enriched yeast is prepared by performing stage-by-stage expanded culture of a yeast strain, performing fe...
|
|
WO/2023/012370A1 |
An artificial alkane oxidation system comprising components: a. an oxidase enzyme; and b. one or more enzymes to provide one or more alkanes. The artificial alkane oxidation system optionally has c. an electron transfer compound suitable...
|
|
WO/2023/010820A1 |
Disclosed is a method for purifying indole-3-lactic acid from a lactobacillus plantarum fermentation supernatant, utilizing a fermentation supernatant of lactobacillus plantarum ZJ316 having a deposit number of CCTCC NO: M 208077, and co...
|
|
WO/2023/006827A1 |
The invention relates to a method of making a product for human consumption which comprises partially lysed microalgae, said method comprising a) preparing a suspension of microalgae, wherein the microalgae belong to a phylaselected from...
|
|
WO/2023/004770A1 |
Provided are a Pichia pastoris expression vector of fructosamine deglycase, a genetically engineered bacterium and a construction method therefor, and a protein expression method. The Pichia pastoris expression vector of fructosamine deg...
|
|
WO/2023/004784A1 |
Provided are a recombinant CHO cell, a construction method therefor, a detection system containing same, and a detection method using same. The recombinant CHO cell stably expresses NGF on the surface thereof and can be used as a target ...
|
|
WO/2023/006883A1 |
Provided herein are compositions and methods useful for producing thermophilic fermented dairy compositions, such as thermophilic fermented dairy products, having cream flavor. The compositions and methods provided herein include bacteri...
|
|
WO/2023/004901A1 |
Provided are a group of GH10 family high-temperature-resistant xylanase mutants and the use thereof. By means of rational design, the GH10 family xylanase HwXyl10A gene cloned from fungus Hortaea werneckii is subjected to site-directed m...
|
|
WO/2023/006885A1 |
Provided herein are compositions and methods for producing fermented plant-based compositions, e.g., fermented dairy alternative food products, having cream flavor. The compositions and methods provided herein include bacteria, e.g., Lac...
|
|
WO/2023/004983A1 |
Provided are a strain of Leuconostoc citreum and the use thereof. The strain has the taxonomic name Leuconostoc citreum and a deposit number of CGMCC NO. 6431. The genome of the strain has two genes encoding levansucrases that are contin...
|
|
WO/2023/006917A1 |
The present invention relates to microorganism compositions and fertilisers comprising them, which reduce soil nitrate accumulation and their use for avoiding nitrogen leaching.
|
|
WO/2023/004969A1 |
Provided are an esterase mutant and the use thereof. The esterase mutant obtained by means of rational design and several rounds of evolution screening with enzymes on the basis of an amino acid sequence as shown in SEQ ID NO: 1 is chang...
|
|
WO/2023/000612A1 |
Disclosed are a fungicide for botryodiplodia theobromae and the use thereof. Lysinibacillus boronitolerans or fermentation liquor thereof is prepared into the fungicide for botryodiplodia theobromae.
|
|
WO/2023/000618A1 |
Provided are a Bacillus xiaoxiensis STB08 for producing a β-cyclodextrin glucosyltransferase, and a method for preparing the β-cyclodextrin glucosyltransferase by using the Bacillus xiaoxiensis STB08. Also provided is the β-cyclodextr...
|
|
WO/2023/003175A1 |
The present invention relates to a novel Lactobacillus paracasei ATG-E1 strain (Accession No: KCTC 14245BP) and a composition comprising same for preventing or treating a respiratory disease, wherein the respiratory disease is induced by...
|
|
WO/2023/004172A1 |
Provided are systems and methods for production of recombinant proteins in engineered microorganisms while reducing impurities produced in the culture.
|
|
WO/2023/001633A1 |
The present invention relates to bacterial strains of Lactococcus lactis or Lactococcus cremoris, usable as starter cultures, able to provide both satisfactory rheological and organoleptic proper-ties, and satisfactory shelf life to a pl...
|
|
WO/2023/000492A1 |
Provided in the present invention is a strain of Paenibacillus sp. for synthesizing an exopolysaccharide by means of fermenting wheat bran, and the deposit number of the strain is CGMCC NO. 8333; the exopolysaccharide synthesized has a w...
|
